GlassScriptPhysician profile
Aaron Manmohan Gandhi
NPI 1346810066
$1,981.61
in general payments reported to CMS, 2019-2025
14 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $217 · 2023: $313 · 2024: $869 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $563.31 | 2021-2025 | |
| Glaxosmithkline, LLC. | $223.13 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $217.36 | 2022-2024 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $189.87 | 2022-2024 | Ofev |
| Inari Medical, INC. | $166.67 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Genzyme Corporation | $150.00 | 2024 | |
| Insmed, INC. | $150.00 | 2025 | Brinsupri |
| Janssen Pharmaceuticals, INC | $109.62 | 2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $88.40 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $40.65 | 2024 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $21.70 | 2023 | Opsumit, Uptravi |
| Becton, Dickinson and Company | $21.69 | 2024 | Accucath |
| Teva Pharmaceuticals USA, INC. | $21.52 | 2023 | Austedo Xr |
| Lilly USA, LLC | $17.69 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Gandhi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.